Epigenetic regulation in cardiovascular disease: mechanisms and advances in clinical trials

Y Shi, H Zhang, S Huang, L Yin, F Wang… - … and Targeted Therapy, 2022 - nature.com
Epigenetics is closely related to cardiovascular diseases. Genome-wide linkage and
association analyses and candidate gene approaches illustrate the multigenic complexity of …

Pharmacological modulation of autophagy: therapeutic potential and persisting obstacles

L Galluzzi, JM Bravo-San Pedro, B Levine… - Nature reviews Drug …, 2017 - nature.com
Autophagy is central to the maintenance of organismal homeostasis in both physiological
and pathological situations. Accordingly, alterations in autophagy have been linked to …

Autophagy and mitophagy in cardiovascular disease

JM Bravo-San Pedro, G Kroemer, L Galluzzi - Circulation research, 2017 - Am Heart Assoc
Autophagy contributes to the maintenance of intracellular homeostasis in most cells of
cardiovascular origin, including cardiomyocytes, endothelial cells, and arterial smooth …

Pathophysiology of cardiac hypertrophy and heart failure: signaling pathways and novel therapeutic targets

YK Tham, BC Bernardo, JYY Ooi, KL Weeks… - Archives of …, 2015 - Springer
The onset of heart failure is typically preceded by cardiac hypertrophy, a response of the
heart to increased workload, a cardiac insult such as a heart attack or genetic mutation …

[HTML][HTML] Long noncoding RNA p21 enhances autophagy to alleviate endothelial progenitor cells damage and promote endothelial repair in hypertension through …

C Li, L Lin, L Zhang, R Xu, X Chen, J Ji, Y Li - Pharmacological Research, 2021 - Elsevier
Vascular damage of hypertension has been the focus of hypertension treatment, and
endothelial progenitor cells (EPCs) play an important role in the repair of vascular …

[HTML][HTML] Exosomes derived from mesenchymal stem cells rescue myocardial ischaemia/reperfusion injury by inducing cardiomyocyte autophagy via AMPK and Akt …

L Liu, X **, CF Hu, R Li, Z Zhou… - Cellular physiology and …, 2017 - karger.com
Background/Aims: Reperfusion after an ischaemic insult might cause infarct extension.
Mesenchymal stem cell (MSC)-derived exosomes could attenuate myocardial remodelling in …

Doxorubicin blocks cardiomyocyte autophagic flux by inhibiting lysosome acidification

DL Li, ZV Wang, G Ding, W Tan, X Luo, A Criollo… - Circulation, 2016 - Am Heart Assoc
Background—The clinical use of doxorubicin is limited by cardiotoxicity. Histopathological
changes include interstitial myocardial fibrosis and the appearance of vacuolated …

Cardioprotective mechanism of SGLT2 inhibitor against myocardial infarction is through reduction of autosis

K Jiang, Y Xu, D Wang, F Chen, Z Tu, J Qian… - Protein & …, 2022 - academic.oup.com
ABSTRACT Sodium-glucose cotransporter 2 (SGLT2) inhibitors reduce cardiovascular
mortality in patients with diabetes mellitus but the protective mechanism remains elusive …

The role of sirtuins in cardiac disease

S Matsushima, J Sadoshima - American Journal of …, 2015 - journals.physiology.org
Modification of histones is one of the important mechanisms of epigenetics, in which genetic
control is determined by factors other than an individual's DNA sequence. Sirtuin family …

Targeting mitochondria for cardiovascular disorders: therapeutic potential and obstacles

M Bonora, MR Wieckowski, DA Sinclair… - Nature Reviews …, 2019 - nature.com
A large body of evidence indicates that mitochondrial dysfunction has a major role in the
pathogenesis of multiple cardiovascular disorders. Over the past 2 decades, extraordinary …